Quantitative systems-level determinants of drug targets by unknown
BioMed CentralBMC Bioinformatics
ssOpen AccePoster presentation
Quantitative systems-level determinants of drug targets
Lixia Yao*1 and Andrey Rzhetsky2
Address: 1Department of Biomedical Informatics, Center for Computational Biology and Bioinformatics, Columbia University, New York, NY 
10032, USA and 2Department of Medicine, Department of Human Genetics, Institute for Genomics and Systems Biology, and Computation 
Institute, University of Chicago, IL 60637, USA
Email: Lixia Yao* - ly2142@columbia.edu
* Corresponding author    
Background
Modern drug discovery tends to understand disease proc-
esses at the molecular level and then determine optimal
molecular targets for drug intervention. Inferences have
made from all available drug targets, such as how many
drug targets there are, or how many novel drug targets
could be potentially found in the human genome, to what
functional families these proteins belong, and what struc-
tural properties make them bind to small molecules
tightly and specifically. But all these are very intuitive and
qualitative. The key question of which gene or protein in
a disease process could be a successful drug target remains
unanswered.
Results
We analyzed specific systems-level properties of human
genes and proteins targeted by 919 FDA-approved drugs
[1] and identified a number of quantitative measures that
distinguish them from other genes and proteins at a
highly significant level. Compared to an average gene and
its encoded protein(s), successful drug targets are more
highly connected in a molecular interaction network, but
are far from being the most highly connected; they have
higher betweenness values, lower entropies of tissue
expression, and lower ratios of non-synonymous to syn-
onymous single-nucleotide polymorphisms (see Figure
1). We also tested the performance of different classifica-
tion algorithms (see Figure 2). Furthermore, we have
identified human tissues significantly over- or under-tar-
geted relative to the full spectrum of genes active in each
tissue.
We also built a machine-learning model to demonstrate
the usefulness of these quantitative descriptors for predict-
ing drug targets. With increasing availability of experi-
mental data, we foresee that screening the whole human
genome for potential novel drug targets could be feasible
in near future.
Conclusion
We found that genes associated with successful FDA-
approved drugs have a number of properties at the net-
work, sequence, and tissue-expression levels that signifi-
cantly distinguish them from other human genes.
Although the drug-target-selection guidelines that we sug-
gest cannot replace expensive experiments, they can help
pharmaceutical researchers narrow the prospective set of
drug targets at the earliest stage of a drug development
project. Specifically, when the pharmaceutical company
must decide which target to pursue among pathologic
pathways that are not fully understood, connectivity,
betweenness, Cratio, and entropy might be useful quantita-
tive estimates of each prospective target's expected success
rate.
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(A) Connectivity distribution for the entire molecular network; (B) Targets of the successful drugs are significantly more con-
nected than an average gene in the network, but are not the most highly connected genes in the network; (C) Drug targets 
tend to have higher than average betweenness values; (D) The successful drug targets are not statistically different from the 
rest of the genes in terms of their clustering coefficients; (E-F): Analysis of the ratio (Cratio) of the number of non-synonymous 
to synonymous single-nucleotide polymorphisms (SNPs): (E) Successful drug targets have significantly smaller Cratio than human 
genes on average. (F) The value of Cratio tends to correlate negatively with the gene's connectivity in the network.Page 2 of 3
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Receiver operating characteristic (ROC) curves for the four classificati n algorithms that we used in this studyFigure 2
Receiver operating characteristic (ROC) curves for the four 
classification algorithms that we used in this study. All four 
methods that we tested performed significantly better than 
baseline (ROC score of 0.5, corresponding to a random-
guess method). The logistic regression performed best.Page 3 of 3
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